A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema
Clinical trial NCT06181227 · TERMINATED
Trial details
- NCT number
- NCT06181227
- Sponsor
- Aviceda Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-30
- Primary completion
- 2024-04-05
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.